http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-202192319-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 |
| filingDate | 2020-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-202192319-A1 |
| titleOfInvention | COMPOSITIONS CONTAINING 5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR USE IN THE TREATMENT OF MENTAL DISORDERS |
| abstract | Compositions are provided for use in the treatment of a patient suffering from a mental disorder, in particular clinical depression, intractable depressive disorder, anxiety disorder, post-traumatic stress disorder, body dysmorphic disorder, obsessive-compulsive disorder, eating disorder and substance abuse. In addition, dosing regimens for the treatment of these disorders are provided. |
| priorityDate | 2019-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581970 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1832 |
Total number of triples: 12.